Brief: Perspective Therapeutics Q3 EPS USD -0.35
10/11/2025 21:05
Nov 10 (Reuters) - Perspective Therapeutics Q3 operating income USD -27.861 million. Q3 net income from cont ops USD -25.969 million Q3 net income USD -25.969 million Q3 grant revenue USD 209 thousand
Recent news on Perspective Therapeutics
See all newsPerspective Therapeutics Q2 net loss widens on higher R&D costs
Brief: Perspective Therapeutics Q2 EPS USD -0.22
Brief: Perspective Therapeutics Expands Therapeutic Focus Areas First Patient Dosed With Vmt-Α-Net In The Meningioma Cohort Of A Phase 1/2A Study
Brief: Perspective Therapeutics Q1 EPS USD -0.25
Perspective Therapeutics rises as experimental cancer drug shows promise